A comparative study of some commercially available tests for rheumatoid factor

Area of Science:

• Rheumatology
• Immunology
• Clinical Diagnostics

Background:

• Rheumatoid factor (RF) is a key biomarker in diagnosing rheumatoid arthritis and other joint diseases.
• Numerous commercial assays exist for RF detection, varying in methodology and performance.
• Standardization and comparison of these tests are crucial for accurate clinical application.

Purpose of the Study:

• To evaluate and compare the performance of seven commercial rheumatoid factor screening tests and two quantitative tests.
• To determine the most satisfactory currently available tests for RF detection in patients with joint diseases.
• To provide guidance on selecting reliable RF assays for clinical use.

Main Methods:

• A comparative study was conducted on 477 serum samples from patients with various joint diseases.
• Seven commercially available RF screening tests and two quantitative RF tests were assessed.
• Results were compared against the established Rose-Waaler test as a standard.

Main Results:

• Significant variations in results were observed among the evaluated commercial RF tests.
• The performance and agreement with the Rose-Waaler standard differed markedly between assays.
• Specific tests demonstrated superior or inferior performance characteristics.

Conclusions:

• Not all commercially available rheumatoid factor tests perform equally well.
• The choice of RF assay can significantly impact diagnostic accuracy in joint diseases.
• Recommendations are provided for selecting the most reliable RF tests based on this comparative analysis.